Brief: AnGes MG plans cooperation with Vical Inc on development of genetic medication for Chronic Hepatitis B

AnGes

04/04/2017 09:08

April 4 (Reuters) - AnGes MG Inc  4563.T  : 
     
    * Says co enters into a cooperation contract with a US-based 
firm Vical Incorporated, on joint development of genetic 
medication for treatment of Chronic Hepatitis B 
     
    Source text in Japanese: https://goo.gl/kNoYpP 
    Further company coverage: 4563.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 62674724; 
Reuters Messaging: Cheng.Li@thomsonreuters.com@reuters.net))